tirofiban has been researched along with Cardiac Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avellino, R; Biondi-Zoccai, G; Carulli, E; Cavarretta, E; Conte, S; Corcione, N; Ferraro, P; Giordano, A; Morello, A; Pepe, M | 1 |
| Jia, D; Li, Y; Nie, X; Yan, Z; Zhao, Y; Zhou, Y; Zhou, Z | 1 |
| Willerson, JT; Wu, KK | 1 |
| Berger, PB; Braden, GA; Casterella, PJ; Dangas, G; Gallo, R; Holmes, DR; Jia, G; Kereiakes, DJ; Lincoff, AM; Moliterno, DJ; Navetta, FI; Popma, JJ; Sane, DC; Saucedo, JF; Steinhubl, SR; Talley, JD; Tcheng, JE; Teirstein, PS; Theroux, P | 1 |
2 trial(s) available for tirofiban and Cardiac Diseases
| Article | Year |
|---|---|
Efficacy and safety of tirofiban in high-risk patients with non-ST-segment elevation acute coronary syndromes.
Topics: Acute Coronary Syndrome; Aged; Angioplasty, Balloon, Coronary; Biomarkers; Creatine Kinase, MB Form; Double-Blind Method; Electrocardiography; Female; Heart Diseases; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Risk Assessment; Thrombocytopenia; Time Factors; Tirofiban; Treatment Outcome; Troponin I; Tyrosine | 2009 |
Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention: results of the GOLD (AU-Assessing Ultegra) multicenter study.
Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Blood Platelets; Cohort Studies; Eptifibatide; Female; Heart Diseases; Humans; Immunoglobulin Fab Fragments; Logistic Models; Male; Multivariate Analysis; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Risk Factors; Time Factors; Tirofiban; Tyrosine | 2001 |
2 other study(ies) available for tirofiban and Cardiac Diseases
| Article | Year |
|---|---|
Impact of Tirofiban on Serum Troponin Changes in Patients Undergoing Carotid Artery Stenting: A Propensity Matched Analysis.
Topics: Aged; Anticoagulants; Biomarkers; Carotid Artery Diseases; Databases, Factual; Dual Anti-Platelet Therapy; Endovascular Procedures; Female; Heart Diseases; Heparin; Humans; Male; Platelet Aggregation Inhibitors; Propensity Score; Retrospective Studies; Risk Assessment; Risk Factors; Stents; Time Factors; Tirofiban; Treatment Outcome; Troponin | 2020 |
Monitoring platelet function in glycoprotein IIB/IIIA inhibitor therapy.
Topics: Abciximab; Antibodies, Monoclonal; Eptifibatide; Heart Diseases; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Tyrosine | 2001 |